- Home
- INM vs TRIB Comparison
INM vs TRIB Comparison
Compare INM & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INM | TRIB |
|---|---|---|
| Founded | 1981 | 1992 |
| Country | Canada | Ireland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.7M | 8.4M |
| IPO Year | 2020 | 1996 |
Fundamental Metrics
Financial Performance| Metric | INM | TRIB |
|---|---|---|
| Price | $1.30 | $7.55 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 66.3K | 26.9K |
| Earning Date | 05-12-2026 | 05-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.68 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,942,633.00 | N/A |
| Revenue This Year | N/A | $13.51 |
| Revenue Next Year | N/A | $13.14 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7.50 | N/A |
| 52 Week Low | $0.58 | $0.28 |
| 52 Week High | $2.50 | $14.17 |
Technical Indicators
Market Signals| Indicator | INM | TRIB |
|---|---|---|
| Relative Strength Index (RSI) | 36.87 | 38.37 |
| Support Level | $1.03 | $0.55 |
| Resistance Level | $1.40 | $14.03 |
| Average True Range (ATR) | 0.08 | 0.75 |
| MACD | -0.01 | -0.51 |
| Stochastic Oscillator | 5.97 | 12.67 |
Price Performance
Historical ComparisonAbout INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has three segments, namely the Americas, Asia/Africa, and Europe, from which it derives a majority of its revenue from the Americas segment.